​
Login / Signup
Xia Zhu
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Poor Prognosis
Tyrosine Kinase
Dna Damage
Epidermal Growth Factor Receptor
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shaoxing Guan
,
Xi Chen
,
Yuru Wei
,
Fei Wang
,
Wen Xie
,
Youhao Chen
,
Heng Liang
,
Xia Zhu
,
Yunpeng Yang
,
Wenfeng Fang
,
Yan Huang
,
Hongyun Zhao
,
Xiao-Xu Zhang
,
Shu Liu
,
Wei Zhuang
,
Min Huang
,
Xue-Ding Wang
,
Li Zhang
Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (7) (2024)
Shaoxing Guan
,
Xi Chen
,
Yuru Wei
,
Fei Wang
,
Wen Xie
,
Youhao Chen
,
Heng Liang
,
Xia Zhu
,
Yunpeng Yang
,
Wenfeng Fang
,
Yan Huang
,
Hongyun Zhao
,
Xiao-Xu Zhang
,
Shu Liu
,
Wei Zhuang
,
Min Huang
,
Xue-Ding Wang
,
Li Zhang
Germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression in non-small cell lung cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Shaoxing Guan
,
Xi Chen
,
Yuru Wei
,
Fei Wang
,
Wen Xie
,
Youhao Chen
,
Heng Liang
,
Xia Zhu
,
Yunpeng Yang
,
Wenfeng Fang
,
Yan Huang
,
Hongyun Zhao
,
Xiao-Xu Zhang
,
Shu Liu
,
Wei Zhuang
,
Min Huang
,
Xue-Ding Wang
,
Li Zhang
Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (7) (2024)